Confirmation of chromosomal microarray as a first-tier clinical diagnostic test for individuals with developmental delay, intellectual disability, autism spectrum disorders and dysmorphic features

Agatino Battaglia, Viola Doccini, Laura Bernardini, Antonio Novelli, Sara Loddo, Anna Capalbo, Tiziana Filippi, John C. Carey

Research output: Contribution to journalArticlepeer-review

Abstract

Background and objectives: Submicroscopic chromosomal rearrangements are the most common identifiable causes of intellectual disability and autism spectrum disorders associated with dysmorphic features. Chromosomal microarray (CMA) can detect copy number variants

Original languageEnglish
Pages (from-to)589-599
Number of pages11
JournalEuropean Journal of Paediatric Neurology
Volume17
Issue number6
DOIs
Publication statusPublished - Nov 2013

Keywords

  • Array-CGH
  • Autism spectrum disorders
  • Chromosomal microarray (CMA)
  • Developmental delay
  • Dysmorphic features
  • Intellectual disability
  • Neurodevelopmental disorders

ASJC Scopus subject areas

  • Clinical Neurology
  • Pediatrics, Perinatology, and Child Health

Fingerprint Dive into the research topics of 'Confirmation of chromosomal microarray as a first-tier clinical diagnostic test for individuals with developmental delay, intellectual disability, autism spectrum disorders and dysmorphic features'. Together they form a unique fingerprint.

Cite this